Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
6.78
+0.43 (6.77%)
Dec 26, 2024, 4:00 PM EST - Market closed
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $224.19 million as of December 27, 2024. Its market cap has decreased by -16.61% in one year.
Market Cap
224.19M
Enterprise Value
77.57M
1-Year Change
-16.61%
Ranking
Category
Stock Price
$6.78
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has decreased from $271.36M to $224.19M, a decrease of -17.38%. That is a compound annual growth rate of -15.39%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 24, 2024 | 209.97M | -41.28% |
Dec 29, 2023 | 357.58M | 31.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Perspective Therapeutics | 215.60M |
Alpha Tau Medical | 213.28M |
Inhibrx Biosciences | 212.80M |
Cardiff Oncology | 212.72M |
Ocugen | 212.40M |
Profound Medical | 209.33M |
Utah Medical Products | 209.26M |
Biodesix | 208.02M |